Center-Authored Papers

Filters: Author is Porter, Peggy L  [Clear All Filters]
2008
Gadi VK, Malone KE, Guthrie KA, Porter PL, Nelson JL.  2008.  Case-control study of fetal microchimerism and breast cancer.. PloS one. 3(3):e1706. Abstract
Phipps AI, Malone KE, Porter PL, Daling JR, Li CI.  2008.  Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(8):2078-86. Abstract
Reding KW, Daling JR, Doody DR, O'Brien CA, Porter PL, Malone KE.  2008.  Effect of prediagnostic alcohol consumption on survival after breast cancer in young women.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(8):1988-96. Abstract
Loo LWM, Ton C, Wang Y-W, Grove DI, Bouzek H, Vartanian N, Lin M-G, Yuan X, Lawton TL, Daling JR et al..  2008.  Differential patterns of allelic loss in estrogen receptor-positive infiltrating lobular and ductal breast cancer.. Genes, chromosomes & cancer. 47(12):1049-66. Abstract
Beaber EF, Holt VL, Malone KE, Porter PL, Daling JR, Li CI.  2008.  Reproductive factors, age at maximum height, and risk of three histologic types of breast cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(12):3427-34. Abstract
Mathes RW, Malone KE, Daling JR, Porter PL, Li CI.  2008.  Relationship between histamine2-receptor antagonist medications and risk of invasive breast cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(1):67-72. Abstract
Li CI, Malone KE, Porter PL, Lawton TJ, Voigt LF, Cushing-Haugen KL, Lin MG, Yuan X, Daling JR.  2008.  Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(1):43-50. Abstract
Mathes RW, Malone KE, Daling JR, Davis S, Lucas SM, Porter PL, Li CI.  2008.  Migraine in postmenopausal women and the risk of invasive breast cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(11):3116-22. Abstract
Phipps AI, Malone KE, Porter PL, Daling JR, Li CI.  2008.  Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer.. Cancer. 113(7):1521-6. Abstract
McTiernan A, Porter PL, Potter JD.  2008.  Breast cancer prevention in countries with diverse resources.. Cancer. 113(8 Suppl):2325-30. Abstract
2009
Porter PL.  2009.  Global trends in breast cancer incidence and mortality.. Salud pública de México. 51 Suppl 2:s141-6. Abstract
Dolle JM, Daling JR, White E, Brinton LA, Doody DR, Porter PL, Malone KE.  2009.  Risk factors for triple-negative breast cancer in women under the age of 45 years.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(4):1157-66. Abstract
Tubbs R, Barlow WE, Budd TG, Swain E, Porter PL, Gown A, Yeh I-T, Sledge G, Shapiro C, Ingle J et al..  2009.  Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(24):3881-6. Abstract
Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, Flagg EW, O'Regan RM, Gabram SGA, Eley WJ.  2009.  Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.. Breast cancer research and treatment. 113(2):357-70. Abstract
Li CI, Daling JR, Porter PL, Tang M-TC, Malone KE.  2009.  Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor-positive invasive breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(32):5312-8. Abstract
Trivers KF, Lund MJ, Porter PL, Liff JM, Flagg EW, Coates RJ, Eley WJ.  2009.  The epidemiology of triple-negative breast cancer, including race.. Cancer causes & control : CCC. 20(7):1071-82. Abstract
Li CI, Daling JR, Porter PL, Tang M-TC, Malone KE.  2009.  Adjuvant hormonal therapy for breast cancer and risk of hormone receptor-specific subtypes of contralateral breast cancer.. Cancer research. 69(17):6865-70. Abstract
2010
Harigopal M, Barlow WE, Tedeschi G, Porter PL, Yeh I-T, Haskell C, Livingston R, Hortobagyi GN, Sledge G, Shapiro C et al..  2010.  Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome.. The American journal of pathology. 176(4):1639-47. Abstract
Nelson ZC, Ray RM, Wu C, Stalsberg H, Porter PL, Lampe JW, Shannon J, Horner N, Li W, Wang W et al..  2010.  Fruit and vegetable intakes are associated with lower risk of breast fibroadenomas in Chinese women.. The Journal of nutrition. 140(7):1294-301. Abstract
2011
Reding KW, Doody DR, McTiernan A, Hsu L, Davis S, Daling JR, Porter PL, Malone KE.  2011.  Age-related variation in the relationship between menopausal hormone therapy and the risk of dying from breast cancer.. Breast cancer research and treatment. 126(3):749-61. Abstract
Phipps AI, Buist DSM, Malone KE, Barlow WE, Porter PL, Kerlikowske K, Li CI.  2011.  Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk.. Breast cancer research and treatment. 126(3):671-8. Abstract
Harford JB, Otero IV, Anderson BO, Cazap E, Gradishar WJ, Gralow JR, Kane GM, Niëns LM, Porter PL, Reeler AV et al..  2011.  Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative.. Breast (Edinburgh, Scotland). 20 Suppl 2:S20-9. Abstract
Malone KE, Daling JR, Doody DR, O'Brien C, Resler A, Ostrander EA, Porter PL.  2011.  Family History of Breast Cancer in Relation to Tumor Characteristics and Mortality in a Population-Based Study of Young Women with Invasive Breast Cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(12):2560-2571. Abstract
Ton CC, Vartanian N, Chai X, Lin MG, Yuan X, Malone KE, Li CI, Dawson A, Sather C, Delrow JJ et al..  2011.  Gene expression array testing of FFPE archival breast tumor samples: an optimized protocol for WG-DASL sample preparation.. Breast cancer research and treatment. 125(3):879-83. Abstract
Phipps AI, Buist DSM, Malone KE, Barlow WE, Porter PL, Kerlikowske K, Li CI.  2011.  Reproductive history and risk of three breast cancer subtypes defined by three biomarkers.. Cancer causes & control : CCC. 22(3):399-405. Abstract